Senior Vice President, Outcome Capital
Oded Ben-Joseph, PhD, MBA
Managing Director, Outcome Capital
As a highly specialized life science advisory and investment banking firm, Outcome Capital looks to identify emerging trends that effect how researchers and clinicians understand, diagnose, and treat disease. One emerging trend we have noted is the integration of advancements in biological sciences, such as tools and techniques, and digital technolo- gies, such as machine learning (ML) and artificial intelligence (AI). This merger has given rise to a new field – spatial biology.
The Contract Waterfall: Important Financial Tool in a Federal Government Contractor’s Toolset The contract waterfall plays an important role for both the buyer and the seller in an acquisition and is arguably the most important information that parties will use in the due diligence process What is a Contract Waterfall? The contract waterfall sets forth […]Read More
Outcome Capital Advises Forward Photonics in its Sale April 24, 2020, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth companies in aerospace, defense and government services, technology, life sciences and healthcare, is pleased to announce that Forward Photonics, LLC (the “Company”) has been acquired by an undisclosed private equity […]Read More